SEC Form 4 · accession 0001127602-15-029494
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Oct 22, 2015
Accepted (ET)
Oct 23, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 22, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF3 | Oct 22, 2015 | S | 694 | $123.0009 | D | 3,661 | D | |
| Common StockF4 | Oct 22, 2015 | S | 3,421 | $123.8063 | D | 240 | D | |
| Common StockF2 | Oct 22, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF5 | Oct 22, 2015 | S | 800 | $118.6025 | D | 4,987 | D | |
| Common StockF6 | Oct 22, 2015 | S | 447 | $119.563 | D | 4,540 | D | |
| Common StockF7 | Oct 22, 2015 | S | 1,900 | $120.9911 | D | 2,640 | D | |
| Common StockF8 | Oct 22, 2015 | S | 600 | $121.9983 | D | 2,040 | D | |
| Common StockF9 | Oct 22, 2015 | S | 1,100 | $123.1618 | D | 940 | D | |
| Common StockF10 | Oct 22, 2015 | S | 700 | $124.0343 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $34.56 | Oct 22, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 16,475 | D |
| Stock Options | $30.75 | Oct 22, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 343,879 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F10This transaction was executed in multiple trades at prices ranging from $123.81 to $124.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $122.3901 to $123.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $123.4250 to $124.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $118.14 to $119.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $119.395 to $119.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $120.61 to $121.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $121.73 to $122.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $122.78 to $123.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.